Key Takeaways
BillionToOne's Northstar Response blood test predicted survival better than standard-of-care imaging for advanced cancer patients on immunotherapy, in a peer-reviewed study.
The study covered 142 patients across 12 solid tumor types and was reproduced in an independent validation group.
The blood test flagged disease progression earlier than imaging, by roughly two months in the cases that drew attention online.
A blood test outperformed medical imaging at predicting how cancer patients would respond to treatment. In a peer-reviewed study, BillionToOne's Northstar Response was a stronger predictor of survival than standard-of-care imaging for patients with advanced solid tumors on immunotherapy. The work covered 142 patients across 12 tumor types.
What the test does
Northstar Response reads tumor-specific signals in a blood draw. It uses single-molecule sequencing and a counting method the company calls Quantitative Counting Template to measure tiny changes in tumor DNA, tracking whether a treatment is working without waiting for a scan. In the study, run with the Allegheny Health Network Cancer Institute, the blood test flagged progression earlier than imaging, by roughly two months in the cases investor Seth Bannon highlighted.
Why earlier matters
Imaging has guided oncology for decades, but a scan can only show change after a tumor has grown or shrunk enough to see. A blood test that catches the signal sooner could let doctors switch a failing immunotherapy weeks earlier, before a patient loses time on a drug that is not working. The study reproduced its results in an independent group of patients, and the researchers found that adding the molecular test to imaging predicted outcomes better than imaging alone, rather than replacing scans outright.
Part of a wider shift
The result fits a run of tools chipping away at the cost and delay of legacy diagnostics, from Midjourney's body scanner that aims to beat the MRI on cost and speed to Cadence's connected-device monitoring for chronic care. The pattern is the same. Move the signal earlier and out of the hospital, and the standard of care starts to shift.
People Also Ask
What is BillionToOne's Northstar Response?
Northstar Response is a blood test that measures tumor-specific DNA signals to track whether a cancer treatment is working, using single-molecule sequencing and BillionToOne's Quantitative Counting Template method.
Did the blood test replace imaging?
No. The study found that adding Northstar Response to standard imaging predicted survival better than imaging alone, so it complements scans rather than replacing them.
How large was the study?
It covered 142 patients across two independent cohorts and 12 solid tumor types, conducted with the Allegheny Health Network Cancer Institute and reproduced in a prospective validation group.
Why does earlier detection matter in cancer care?
Catching that a treatment is failing sooner can let doctors change course weeks earlier, before a patient loses time on an immunotherapy that is not working.